Sydney Liang is a Dermatology physician affiliated with New York University. OpenAlex indexes 13 publications with 294 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
240 E 38th St Fl 12
New York, NY 100162708
Telephone
212-263-5250Provider last certified this registry record 29 Jun 2023.
Industry payments
25 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year202552 payments
- SUN PHARMACEUTICAL INDUSTRIES INC.Program year202511 payments
- Incyte CorporationProgram year20258 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
34.4%Azole Antifungal23.7%Ketoconazole100%Part D≥33 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor5.3%Valacyclovir100%Part D<11 patients+ 1 more class in this area
Dermatology
31.3%Corticosteroid27.1%Triamcinolone Acetonide55%Triamcinolone acetonide45%Part D + Part B≥32 patientsAzole Antifungal4.2%Jublia100%Part D<11 patientsSensory organs
22.5%Corticosteroid22.5%Clobetasol Propionate70%Hydrocortisone31%Part D≥22 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The immunogenicity of hepatitis B vaccine in psoriasis patients and by treatment type: A retrospective cohort study
Journal of the European Academy of Dermatology and Venereology
2024 - Improving RNA Fusion Call Confidence and Reliability in Molecular Diagnostic Testing
Journal of Molecular Diagnostics
2023 - The Use of Mycophenolate Mofetil in the Treatment of Bullous Pemphigoid
Journal of Drugs in Dermatology
2022 - Screening for depression and suicidality in psoriasis patients: A survey of US dermatologists
Journal of the American Academy of Dermatology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Galetta, MD
New York University
Herbert Lepor, MD
New York University
Aasma Shaukat, MD
New York University
Jerry Shapiro, MD
New York University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”